1.0
14 Oct 2016
Anonymous employee
Former employee
Recommend
CEO approval
Business outlook
Pros
Size and strength if they figure out what to do with it
Cons
Almost everything, since management and the company as a whole, is run so poorly. The FDA is still pounding on Healthcare and RIFTS are common. They haven't released Spect or CT products from the FDA since 2011... yea 2011. The new CT is just a rebranded Brilliance.